Silver Spike Investment Corp. (SSIC)

USD 10.74

(1.27%)

Revenue Summary of Silver Spike Investment Corp.

  • Silver Spike Investment Corp.'s latest annual revenue in 2023 was 11.72 Million USD , up 189.66% from previous year.
  • Silver Spike Investment Corp.'s latest quarterly revenue in 2024 Q1 was 2.76 Billion USD , up 75226.3% from previous quarter.
  • Silver Spike Investment Corp. reported a annual revenue of 4.04 Million USD in annual revenue 2022, up 40075.37% from previous year.
  • Silver Spike Investment Corp. reported a annual revenue of 10.07 Thousand USD in annual revenue 2021, down 0.0% from previous year.
  • Silver Spike Investment Corp. reported a quarterly revenue of 3.13 Million USD for 2023 Q1, up 53.06% from previous quarter.
  • Silver Spike Investment Corp. reported a quarterly revenue of 3.66 Million USD for 2023 Q4, up 91.95% from previous quarter.

Annual Revenue Chart of Silver Spike Investment Corp. (2023 - 2020)

Historical Annual Revenue of Silver Spike Investment Corp. (2023 - 2020)

Year Revenue Revenue Growth
2023 11.72 Million USD 189.66%
2022 4.04 Million USD 40075.37%
2021 10.07 Thousand USD 0.0%
2020 - USD 0.0%

Peer Revenue Comparison of Silver Spike Investment Corp.

Name Revenue Revenue Difference
ANI Pharmaceuticals, Inc. 486.81 Million USD 97.592%
Aquestive Therapeutics, Inc. 50.58 Million USD 76.826%
Collegium Pharmaceutical, Inc. 566.76 Million USD 97.932%
Cosmos Health Inc. 53.37 Million USD 78.039%
Cyclo Therapeutics, Inc. 1.07 Million USD -989.008%
Esperion Therapeutics, Inc. 116.33 Million USD 89.924%
Cronos Group Inc. 88.84 Million USD 86.805%
Incannex Healthcare Limited 12 Thousand USD -97584.442%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Lifecore Biomedical, Inc. 128.26 Million USD 90.861%
Regencell Bioscience Holdings Limited - USD -Infinity%
Sunshine Biopharma, Inc. 24.09 Million USD 51.346%
Sunshine Biopharma, Inc. 24.09 Million USD 51.346%
SCYNEXIS, Inc. 140.14 Million USD 91.635%
Safety Shot Inc 202.67 Thousand USD -5683.852%
Theratechnologies Inc. 81.76 Million USD 85.663%
Alpha Teknova, Inc. 36.68 Million USD 68.046%
Universe Pharmaceuticals INC 32.3 Million USD 63.718%
Pacira BioSciences, Inc. 674.97 Million USD 98.263%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD 7.953%
Dynavax Technologies Corporation 232.28 Million USD 94.954%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 97.352%
Radius Health, Inc. 2.88 Billion USD 99.593%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -507.838%
Alvotech 91.43 Million USD 87.18%
Intra-Cellular Therapies, Inc. 464.37 Million USD 97.476%
SIGA Technologies, Inc. 139.91 Million USD 91.622%
Shineco, Inc. 9.8 Million USD -19.591%
Journey Medical Corporation 79.18 Million USD 85.196%
Petros Pharmaceuticals, Inc. 5.82 Million USD -101.329%
Embecta Corp. 1.12 Billion USD 98.954%
Harrow Health, Inc. 130.19 Million USD 90.996%
Procaps Group, S.A. 409.92 Million USD 97.14%
Biofrontera Inc. 34.07 Million USD 65.595%
DURECT Corporation 8.54 Million USD -37.133%
PainReform Ltd. - USD -Infinity%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 98.07%
OptiNose, Inc. 70.98 Million USD 83.487%
RedHill Biopharma Ltd. 6.51 Million USD -79.976%
Organogenesis Holdings Inc. 433.14 Million USD 97.294%
Cumberland Pharmaceuticals Inc. 39.55 Million USD 70.363%
ProPhase Labs, Inc. 44.38 Million USD 73.589%
Phibro Animal Health Corporation 1.01 Billion USD 98.848%
Procaps Group S.A. 409.92 Million USD 97.14%
TherapeuticsMD, Inc. 1.3 Million USD -800.317%
Viatris Inc. 15.42 Billion USD 99.924%
Rockwell Medical, Inc. 83.61 Million USD 85.98%
Aytu BioPharma, Inc. 81 Million USD 85.529%
Tilray Brands, Inc. 788.94 Million USD 98.514%
PetIQ, Inc. 1.1 Billion USD 98.936%
Talphera, Inc. 651 Thousand USD -1700.635%
Neurocrine Biosciences, Inc. 1.88 Billion USD 99.379%
Alimera Sciences, Inc. 80.75 Million USD 85.484%
Assertio Holdings, Inc. 152.06 Million USD 92.292%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Avadel Pharmaceuticals plc 27.96 Million USD 58.08%
Hempacco Co., Inc. 4.04 Million USD -189.748%
Alvotech 91.43 Million USD 87.18%
Lantheus Holdings, Inc. 1.29 Billion USD 99.096%
Kamada Ltd. 144.75 Million USD 91.902%
Currenc Group, Inc. 53.25 Million USD 77.989%
Indivior PLC 1.09 Billion USD 98.928%
Evoke Pharma, Inc. 5.18 Million USD -126.268%
Flora Growth Corp. 76.07 Million USD 84.591%
Cyclo Therapeutics, Inc. 1.07 Million USD -989.008%
Evolus, Inc. 202.08 Million USD 94.199%
HUTCHMED (China) Limited 837.99 Million USD 98.601%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 98.181%
Akanda Corp. 2.16 Million USD -442.678%